Cargando…

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair

Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is the most commonly mutated gene in prostate cancer (PCa). Recent evidence reports a role of SPOP in DNA damage response (DDR), indicating a possible impact of SPOP deregulation on PCa radiosensitivity. This study aimed to define t...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Bezawy, Rihan, Tripari, Martina, Percio, Stefano, Cicchetti, Alessandro, Tortoreto, Monica, Stucchi, Claudio, Tinelli, Stella, Zuco, Valentina, Doldi, Valentina, Gandellini, Paolo, Valdagni, Riccardo, Zaffaroni, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352729/ https://www.ncbi.nlm.nih.gov/pubmed/32512734 http://dx.doi.org/10.3390/cancers12061462

Ejemplares similares

miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
por: El Bezawy, Rihan, et al.
Publicado: (2019)

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression
por: Rotundo, Federica, et al.
Publicado: (2020)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
por: Doldi, Valentina, et al.
Publicado: (2021)

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
por: El Bezawy, Rihan, et al.
Publicado: (2017)

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma
por: El Bezawy, Rihan, et al.
Publicado: (2022)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
por: Gandellini, Paolo, et al.
Publicado: (2021)

LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation
por: Profumo, Valentina, et al.
Publicado: (2019)

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
por: Doldi, Valentina, et al.
Publicado: (2015)

Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
por: Zuco, Valentina, et al.
Publicado: (2021)

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft
por: Zuco, Valentina, et al.
Publicado: (2023)

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer
por: Doldi, Valentina, et al.
Publicado: (2022)

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
por: Alessandrini, Irene, et al.
Publicado: (2022)

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy
por: Bedini, Nice, et al.
Publicado: (2018)

MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism
por: Bezzecchi, Eugenia, et al.
Publicado: (2022)

The Roles of SPOP in DNA Damage Response and DNA Replication
por: Maekawa, Masashi, et al.
Publicado: (2020)

SPOP the mutation
por: Rider, Leah, et al.
Publicado: (2015)

miR-21: an oncomir on strike in prostate cancer
por: Folini, Marco, et al.
Publicado: (2010)

PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins
por: Zuco, Valentina, et al.
Publicado: (2015)

Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer
por: Lopergolo, Alessia, et al.
Publicado: (2016)

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
por: Zuco, Valentina, et al.
Publicado: (2011)

Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft
por: Stacchiotti, Silvia, et al.
Publicado: (2019)

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
por: De Cesare, Michelandrea, et al.
Publicado: (2015)

δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
por: Fontana, Fabrizio, et al.
Publicado: (2021)

The establishment of an immunosensor for the detection of SPOP
por: Yue, Song, et al.
Publicado: (2021)

Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation
por: Percio, Stefano, et al.
Publicado: (2020)

Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis
por: Jin, Xiaofeng, et al.
Publicado: (2021)

SPOP targets the immune transcription factor IRF1 for proteasomal degradation
por: Schwartz, Irene, et al.
Publicado: (2023)

SPOP loss of function protects against tauopathy
por: Eck, Randall J., et al.
Publicado: (2022)

A disease-relevant mutation of SPOP highlights functional significance of ATM-mediated DNA damage response
por: Xiao, Mingming, et al.
Publicado: (2021)

SPOP mutation leads to genomic instability in prostate cancer
por: Boysen, Gunther, et al.
Publicado: (2015)

Identification of SPOP related metabolic pathways in prostate cancer
por: Yan, Min, et al.
Publicado: (2017)

The emerging role of SPOP protein in tumorigenesis and cancer therapy
por: Song, Yizuo, et al.
Publicado: (2020)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: Zhu, Qing, et al.
Publicado: (2022)

Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
por: Bernasocchi, Tiziano, et al.
Publicado: (2021)

SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG
por: Tan, Peng, et al.
Publicado: (2019)

Association of SPOP Expression with the Immune Response to Salmonella Infection in Chickens
por: Wang, Fei, et al.
Publicado: (2020)

SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications
por: Yang, Xiaojuan, et al.
Publicado: (2022)

Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_evgvvoumu59hi3op8669sir642